Latest Cancer News

Adding Cediranib to Olaparib Markedly Improves Progression-Free Survival but Increases Toxicity in Recurrent Platinum-Sensitive Ovarian Cancer (10-21-2014)
The addition of the antiangiogenic agent cediranib to the PARP inhibitor olaparib in women with recurrent platinum-sensitive ovarian cancer improves time to cancer progression and survival. The results... Continue Reading

Second-line Avastin Improves Progression-Free Survival in Advanced HER2-Negative Breast Cancer (10-20-2014)
Adding Avastin® (bevacizumab) to chemotherapy in second-line treatment of advanced HER2-negative breast cancer improves progression-free survival. Results of the phase III TANIA trial evaluating the role... Continue Reading

Study Suggest That Psoriasis Patients Have Increased Cancer Risk (10-15-2014)
Based on recently analyzed data from a retrospective analysis of commercial insurance claims, rates of cancer are higher in patients with psoriasis and that some anti-psoriatic drugs may pose a higher... Continue Reading

More Cancer News

Events

Tower Oncology’s Cancer Support Network Brings New Services to West Side
Organizations partner to offer full range of cancer support and education to meet a growing need. Read more…


Tower Hematology Oncology Medical Group Named Fight Back Chair For American Cancer Society’s Relay for Life Event in Beverly Hills
Cancer treatment center seeks volunteers, donations for April 30 cancer support fundraiser
Read more…

Tower News

Tower Hematology Oncology Medical Group has been awarded a three-year term of accreditation in computed tomography (CT) and positron emission tomography (PET) as the result of a recent review by the American College of Radiology (ACR). CT scanning — sometimes called CAT scanning — is a noninvasive medical test that helps physicians diagnose and tailor treatments for various medical conditions. Learn more…

Locations

Tower Hematology Oncology Medical Group
9090 Wilshire Boulevard
Suite 200
Beverly Hills, CA 90211
Phone: (310) 888-8680
Click here for map